Transforming Ordinary Cells with Advanced Technology
CiRC converts one cell type to another using a proprietary cocktail of small molecules and growth factors.
Our allogeneic, off-the-shelf therapies are developed using readily sourced, cGMP-grade cell lines without the use of stem cells, enabling significant competitive and manufacturing advantages.
Transforming Ordinary Cells with Advanced Technology
CiRC converts one cell type to another using a proprietary cocktail of small molecules and growth factors. CiRC’s investigational technology can be used to directly reprogram cells within the body (in-situ) or as a cell replacement therapy.
Transforming Ordinary Cells with Advanced Technology
CiRC converts one cell type to another using a proprietary cocktail of small molecules and growth factors. CiRC’s investigational technology can be used to directly reprogram cells within the body (in-situ) or as a cell replacement therapy.
Cell Replacement Therapy
Cell replacement therapy converts fibroblasts from a master cell bank into photoreceptor or dopaminergic neuron-like cells. The chemically driven method consistently produces a uniform cell group with little or no purification needed. It’s a highly efficient, low-waste process that avoids the complexities of other cell therapies.
Cell Replacement Therapy
Cell replacement therapy converts fibroblasts from a master cell bank into photoreceptor or dopaminergic neuron-like cells. The chemically driven method consistently produces a uniform cell group with little or no purification needed. It’s a highly efficient, low-waste process that avoids the complexities of other cell therapies.
Cell Replacement Therapy
Cell replacement therapy converts fibroblasts from a master cell bank into photoreceptor or dopaminergic neuron-like cells. The chemically driven method consistently produces a uniform cell group with little or no purification needed. It’s a highly efficient, low-waste process that avoids the complexities of other cell therapies.
Pipeline
Pipeline
Pipeline
